{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:49:49Z","timestamp":1787320189757,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidad Cat\u00f3lica de Santiago de Guayaquil","award":["SIU#510-298"],"award-info":[{"award-number":["SIU#510-298"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      The aim of this study was to assess the risk factors for colistin-resistant carbapenemase-producing\n                      <jats:italic>Enterobacterales<\/jats:italic>\n                      (CR-CPE), and describe the mortality associated with this organism, in a low-income country.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A descriptive, observational, and prospective multicenter study was carried out in Guayaquil, Ecuador. All patients with carbapenem-resistant\n                      <jats:italic>Enterobacterales<\/jats:italic>\n                      admitted between December 2021 and May 2022 were enrolled. Infection definitions were established according to the Centers for Disease Control and Prevention (CDC) protocols. The presence of carbapenemase-producing\n                      <jats:italic>Enterobacterales<\/jats:italic>\n                      was confirmed with a multiplex PCR for\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>KPC,<\/jats:sub>\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>NDM,<\/jats:sub>\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>OXA-48,<\/jats:sub>\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>VIM,<\/jats:sub>\n                      and\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>IMP<\/jats:sub>\n                      genes. MCR-1 production was studied molecularly, and MLST assays were carried out.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 114 patients enrolled in the study, 32 (28.07%) had at least one positive sample for CR-CPE.\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      ST512-KPC-3 was the most frequent microorganism isolated. Parenteral feeding, \u03b2-lactamase inhibitor use, recent hemodialysis, and renal failure were all considered independent risk factors for carrying CR-CPE. A mortality of 41.22% was detected, but we could not find any difference between colistin-resistant and colistin-susceptible CPE. MCR-1 production was not detected in any of the isolates studied.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      A significant burden for CR-CPE was found in a South American country that was mainly caused by the high-risk clone\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      ST512-KPC-3 and not mediated by mcr-1 production. Its acquisition involved parenteral feeding, \u03b2-lactamase inhibitor use, recent hemodialysis, and renal failure as independent risk factors, demonstrating the critical need for infection prevention and stewardship programs to avoid dissemination to other countries in the region.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12941-023-00609-8","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T12:02:19Z","timestamp":1690977739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Risk factors associated with colistin resistance in carbapenemase-producing Enterobacterales: a multicenter study from a low-income country"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0896-6291","authenticated-orcid":false,"given":"Soria-Segarra","family":"Claudia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3099-3480","authenticated-orcid":false,"given":"Soria-Segarra","family":"Carmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4289-1131","authenticated-orcid":false,"given":"Diaz","family":"Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9701-100X","authenticated-orcid":false,"given":"Miranda-Ayala","family":"Marcela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9592-1851","authenticated-orcid":false,"given":"Cevallos-Apolo","family":"Kerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8133-9687","authenticated-orcid":false,"given":"Bomb\u00f3n Moreno","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3441-0812","authenticated-orcid":false,"given":"Chuzan J.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6146-9740","authenticated-orcid":false,"given":"Gutierrez-Fern\u00e1ndez","family":"Jos\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,2]]},"reference":[{"key":"609_CR1","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/cid\/ciab696","volume":"74","author":"RE Nelson","year":"2022","unstructured":"Nelson RE, Hyun D, Jezek A, Samore MH. Mortality, length of stay, and healthcare costs associated with multidrug-resistant bacterial infections among elderly hospitalized patients in the United States. Clin Infect Dis. 2022;74:1070\u201380.","journal-title":"Clin Infect Dis"},{"key":"609_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3855\/jidc.13319","volume":"15","author":"C Soria-Segarra","year":"2021","unstructured":"Soria-Segarra C, Soria-Segarra C, Catagua-Gonz\u00e1lez A, Apolo-Matamoros M, Vega-Franco F, Chung-Sang M, et al. Macrolides: a novel risk factor for carbapenemase-producing Enterobacterales in intensive care units. J Infect Dev Ctries. 2021;15:584\u20139.","journal-title":"J Infect Dev Ctries"},{"key":"609_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jiph.2019.06.013","volume":"13","author":"C Soria-Segarra","year":"2020","unstructured":"Soria-Segarra C, Soria-Segarra C, Catagua-Gonz\u00e1lez A, Guti\u00e9rrez-Fern\u00e1ndez J. Carbapenemase producing Enterobacteriaceae in intensive care units in Ecuador: results from a multicenter study. J Infect Public Health. 2020;13:80\u20138.","journal-title":"J Infect Public Health"},{"key":"609_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bjid.2016.09.011","volume":"21","author":"F Rossi","year":"2017","unstructured":"Rossi F, Girardello R, Cury AP, Di Gioia TSR, de Almeida JN, da Duarte AJS. Emergence of colistin resistance in the largest university hospital complex of S\u00e3o Paulo, Brazil, over five years. Braz J Infect Dis. 2017;21:98\u2013101.","journal-title":"Braz J Infect Dis"},{"key":"609_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/ofid\/ofab145","volume":"8","author":"JP Mills","year":"2021","unstructured":"Mills JP, Rojas LJ, Marshall SH, Rudin SD, Hujer AM, Nayak L, et al. Risk factors for and mechanisms of CO listin R esistance among E nterobacterales: getting at the CORE of the issue. Open Forum Infect Dis. 2021;8:145.","journal-title":"Open Forum Infect Dis"},{"key":"609_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/microorganisms7100461","volume":"7","author":"Li Elbediwi","year":"2019","unstructured":"Elbediwi Li, Paudyal P, Li X, et al. Global burden of colistin-resistant bacteria: mobilized colistin resistance genes study (1980\u20132018). Microorganisms. 2019;7:461.","journal-title":"Microorganisms"},{"key":"609_CR7","first-page":"93","volume":"51","author":"C Quiroga","year":"2019","unstructured":"Quiroga C, Nastro M, Di Conza J. Current scenario of plasmid-mediated colistin resistance in Latin America. Rev Argent Microbiol. 2019;51:93\u2013100.","journal-title":"Rev Argent Microbiol"},{"key":"609_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jhin.2016.08.019","volume":"94","author":"I Rossi Gon\u00e7alves","year":"2016","unstructured":"Rossi Gon\u00e7alves I, Ferreira ML, Araujo BF, Campos PA, Royer S, Batist\u00e3o DWF, et al. Outbreaks of colistin-resistant and colistin-susceptible KPC-producing Klebsiella pneumoniae in a Brazilian intensive care unit. J Hosp Infect. 2016;94:322\u20139.","journal-title":"J Hosp Infect"},{"key":"609_CR9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ijantimicag.2019.08.017","volume":"54","author":"LGA Longo","year":"2019","unstructured":"Longo LGA, De Sousa VS, Kraychete GB, Justo-da-Silva LH, Rocha JA, Superti SV, et al. Colistin resistance emerges in pandrug-resistant Klebsiella pneumoniae epidemic clones in Rio de Janeiro. Brazil Int J Antimicrob Agents. 2019;54:579\u201386.","journal-title":"Brazil Int J Antimicrob Agents"},{"key":"609_CR10","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3390\/tropicalmed7120414","volume":"7","author":"NY Yusof","year":"2022","unstructured":"Yusof NY, Norazzman NII, Hakim SNWA, Azlan MM, Anthony AA, Mustafa FH, et al. Prevalence of mutated colistin-resistant Klebsiella pneumoniae: a systematic review and meta-analysis. Trop Med Infect Dis. 2022;7:414.","journal-title":"Trop Med Infect Dis"},{"key":"609_CR11","doi-asserted-by":"publisher","first-page":"716","DOI":"10.17843\/rpmesp.2020.374.5422","volume":"37","author":"A Naomi-Matsuoka","year":"2020","unstructured":"Naomi-Matsuoka A, Vargas M, Yma\u00f1a B, Soza G, Pons MJ. Resistencia a colistina en cepas de Klebsiella pneumoniae multidrogorresistente del per\u00edodo 2015\u20132018 en un hospital materno perinatal de Lima, Per\u00fa. Rev Peru Med Exp Salud P\u00fablica. 2020;37:716\u201320.","journal-title":"Rev Peru Med Exp Salud P\u00fablica"},{"key":"609_CR12","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1017\/S0950268816001369","volume":"144","author":"D Ortega-Paredes","year":"2016","unstructured":"Ortega-Paredes D, Barba P, Zurita J. Colistin-resistant Escherichia coli clinical isolate harbouring the mcr-1 gene in Ecuador. Epidemiol Infect. 2016;144:2967\u201370.","journal-title":"Epidemiol Infect"},{"key":"609_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26633\/RPSP.2023.48","volume":"47","author":"C Bastidas-Caldes","year":"2023","unstructured":"Bastidas-Caldes C, Guerrero-Freire S, Ortu\u00f1o-Guti\u00e9rrez N, Sunyoto T, Gomes-Dias CA, Ram\u00edrez MS, et al. Colistin resistance in Escherichia coli and Klebsiella pneumoniae in humans and backyard animals in Ecuador. Rev Panam Salud P\u00fablica. 2023;47:1.","journal-title":"Rev Panam Salud P\u00fablica"},{"key":"609_CR14","unstructured":"National Healthcare Safety Network. Surveillance Definitions. 2023. https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/17pscnosinfdef_current.pdf"},{"key":"609_CR15","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard","author":"FR Cockerill","year":"2012","unstructured":"Cockerill FR. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 9th ed. Wayne: Pa CLSI; 2012.","edition":"9"},{"key":"609_CR16","unstructured":"Weinstein MP, editor. Performance standards for antimicrobial susceptibility testing. Thirty-first edition. United State of America: Clinical and Laboratory Standards Institute; 2021."},{"key":"609_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","volume":"70","author":"L Poirel","year":"2011","unstructured":"Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70:119\u201323.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"609_CR18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1186\/s12879-016-2072-3","volume":"16","author":"PCS Ribeiro","year":"2016","unstructured":"Ribeiro PCS, Monteiro AS, Marques SG, Monteiro SG, Monteiro-Neto V, Coqueiro MMM, et al. Phenotypic and molecular detection of the blaKPC gene in clinical isolates from inpatients at hospitals in S\u00e3o Luis, MA, Brazil. BMC Infect Dis. 2016;16:737.","journal-title":"BMC Infect Dis"},{"key":"609_CR19","volume-title":"The European health report 2021 taking stock of the health-related sustainable development goals in the COVID-19 era with a focus on leaving no one behind","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. The European health report 2021 taking stock of the health-related sustainable development goals in the COVID-19 era with a focus on leaving no one behind. Copenhagen: World Health Organization; 2022."},{"key":"609_CR20","doi-asserted-by":"publisher","DOI":"10.1705\/.v9i4.13345","author":"RC Deglmann","year":"2019","unstructured":"Deglmann RC, Oliveira DD, Fran\u00e7a PHCD. Perfil fenot\u00edpico de resist\u00eancia \u00e0 colistina e tigeciclina em um hospital p\u00fablico no Brasil. Rev Epidemiol E Controle Infec\u00e7\u00e3o. 2019. https:\/\/doi.org\/10.1705\/.v9i4.13345.","journal-title":"Rev Epidemiol E Controle Infec\u00e7\u00e3o"},{"key":"609_CR21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1099\/jmm.0.000986","volume":"68","author":"P Kaza","year":"2019","unstructured":"Kaza P, Mahindroo J, Veeraraghavan B, Mavuduru RS, Mohan B, Taneja N. Evaluation of risk factors for colistin resistance among uropathogenic isolates of Escherichia coli and Klebsiella pneumoniae: a case\u2013control study. J Med Microbiol. 2019;68:837\u201347.","journal-title":"J Med Microbiol"},{"key":"609_CR22","doi-asserted-by":"publisher","first-page":"1106.e1","DOI":"10.1016\/j.cmi.2015.08.001","volume":"21","author":"DR Giacobbe","year":"2015","unstructured":"Giacobbe DR, Del Bono V, Trecarichi EM, De Rosa FG, Giannella M, Bassetti M, et al. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case\u2013control\u2013control study. Clin Microbiol Infect. 2015;21:1106.e1-1106.e8.","journal-title":"Clin Microbiol Infect"},{"key":"609_CR23","doi-asserted-by":"publisher","first-page":"105882","DOI":"10.1016\/j.ijantimicag.2020.105882","volume":"55","author":"KE da Silva","year":"2020","unstructured":"da Silva KE, Baker S, Croda J, Nguyen TNT, Boinett CJ, Barbosa LS, et al. Risk factors for polymyxin-resistant carbapenemase-producing Enterobacteriaceae in critically ill patients: an epidemiological and clinical study. Int J Antimicrob Agents. 2020;55:105882.","journal-title":"Int J Antimicrob Agents"},{"key":"609_CR24","doi-asserted-by":"publisher","first-page":"831770","DOI":"10.3389\/fmicb.2022.831770","volume":"13","author":"VFD Rocha","year":"2022","unstructured":"Rocha VFD, Barbosa MS, Leal HF, Silva GEO, Sales NMMD, de Monteiro ASS, et al. Prolonged outbreak of carbapenem and colistin-resistant Klebsiella pneumoniae at a large tertiary hospital in Brazil. Front Microbiol. 2022;13:831770.","journal-title":"Front Microbiol"},{"key":"609_CR25","doi-asserted-by":"publisher","first-page":"E23","DOI":"10.1111\/1469-0691.12070","volume":"19","author":"A Capone","year":"2013","unstructured":"Capone A, Giannella M, Fortini D, Giordano A, Meledandri M, Ballardini M, et al. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect. 2013;19:E23-30.","journal-title":"Clin Microbiol Infect"},{"key":"609_CR26","doi-asserted-by":"publisher","first-page":"778","DOI":"10.24953\/turkjped.2020.05.009","volume":"62","author":"Z Hayto\u011flu","year":"2020","unstructured":"Hayto\u011flu Z, G\u00fcnde\u015flio\u011flu \u00d6\u00d6, Y\u0131ld\u0131zda\u015f D, Kocaba\u015f E, Alabaz D, Horoz \u00d6\u00d6. Carbapenem and colistin resistance in children with enterobacteriaceae infections. Turk J Pediatr. 2020;62:778.","journal-title":"Turk J Pediatr"},{"key":"609_CR27","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.30.1700777","author":"AC B\u00fcchler","year":"2018","unstructured":"B\u00fcchler AC, Gehringer C, Widmer AF, Egli A, Tschudin-Sutter S. Risk factors for colistin-resistant Enterobacteriaceae in a low-endemicity setting for carbapenem resistance\u2014a matched case\u2013control study. Eurosurveillance. 2018. https:\/\/doi.org\/10.2807\/1560-7917.ES.2018.23.30.1700777.","journal-title":"Eurosurveillance"},{"key":"609_CR28","doi-asserted-by":"publisher","first-page":"e00149","DOI":"10.1128\/JCM.00149-18","volume":"56","author":"SE Richter","year":"2018","unstructured":"Richter SE, Miller L, Uslan DZ, Bell D, Watson K, Humphries R, et al. Risk factors for colistin resistance among gram-negative rods and Klebsiella pneumoniae isolates. J Clin Microbiol. 2018;56:e00149-e218.","journal-title":"J Clin Microbiol"},{"key":"609_CR29","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.jand.2020.04.024","volume":"120","author":"S Andersen","year":"2020","unstructured":"Andersen S, Banks M, Bauer J. Nutrition support and the gastrointestinal microbiota: a systematic review. J Acad Nutr Diet. 2020;120:1498\u2013516.","journal-title":"J Acad Nutr Diet"},{"key":"609_CR30","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2021.26.21.2000022","author":"SA Baron","year":"2021","unstructured":"Baron SA, Cassir N, Hamel M, Hadjadj L, Saidani N, Dubourg G, et al. Risk factors for acquisition of colistin-resistant Klebsiella pneumoniae and expansion of a colistin-resistant ST307 epidemic clone in hospitals in Marseille, France 2014 to 2017. Eurosurveillance. 2021. https:\/\/doi.org\/10.2807\/1560-7917.ES.2021.26.21.2000022.","journal-title":"Eurosurveillance"},{"key":"609_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4103\/ijccm.IJCCM_454_16","volume":"21","author":"R Arjun","year":"2017","unstructured":"Arjun R, Nambi PS, Kumar DS, Madhumitha R, Ramasubramanian V. A study of 24 patients with colistin-resistant gram-negative isolates in a tertiary care hospital in South India. Indian J Crit Care Med. 2017;21:317\u201321.","journal-title":"Indian J Crit Care Med"},{"key":"609_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.diagmicrobio.2018.06.001","volume":"92","author":"M Papadimitriou-Olivgeris","year":"2018","unstructured":"Papadimitriou-Olivgeris M, Bartzavali C, Spyropoulou A, Lambropoulou A, Sioulas N, Vamvakopoulou S, et al. Molecular epidemiology and risk factors for colistin- or tigecycline-resistant carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients during a 7-year period. Diagn Microbiol Infect Dis. 2018;92:235\u201340.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"609_CR33","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1128\/JCM.01233-11","volume":"49","author":"S Chen","year":"2011","unstructured":"Chen S, Hu F, Zhang X, Xu X, Liu Y, Zhu D, et al. Independent emergence of colistin-resistant Enterobacteriaceae clinical isolates without colistin treatment. J Clin Microbiol. 2011;49:4022\u20133.","journal-title":"J Clin Microbiol"},{"key":"609_CR34","doi-asserted-by":"publisher","first-page":"e00381","DOI":"10.1128\/spectrum.00381-22","volume":"10","author":"P-H Huang","year":"2022","unstructured":"Huang P-H, Chen W-Y, Chou S-H, Wang F-D, Lin Y-T, She RC. Risk factors for the development of colistin resistance during colistin treatment of carbapenem-resistant Klebsiella pneumoniae infections. Microbiol Spectr. 2022;10:e00381-e422.","journal-title":"Microbiol Spectr"},{"key":"609_CR35","first-page":"36","volume":"4","author":"EV Herrera Dutan","year":"2021","unstructured":"Herrera Dutan EV, Andrade Campoverde D, Reinoso Rojas YV, Herrera Dutan EV, Andrade Campoverde D, Reinoso Rojas YV. Resistencia antimicrobiana en Klebsiella pneumoniae. Ecuador Vive Rev Salud. 2021;4:36\u201349.","journal-title":"Ecuador Vive Rev Salud"},{"key":"609_CR36","first-page":"2087","volume":"75","author":"AB Jousset","year":"2020","unstructured":"Jousset AB, Bonnin RA, Takissian J, Girlich D, Mihaila L, Cabanel N, et al. Concomitant carriage of KPC-producing and non-KPC-producing Klebsiella pneumoniae ST512 within a single patient. J Antimicrob Chemother. 2020;75:2087\u201392.","journal-title":"J Antimicrob Chemother"},{"key":"609_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.nmni.2014.09.001","volume":"3","author":"S Bakour","year":"2014","unstructured":"Bakour S, Sahli F, Touati A, Rolain J-M. Emergence of KPC-producing Klebsiella pneumoniae ST512 isolated from cerebrospinal fluid of a child in Algeria. New Microbes New Infect. 2014;3:34\u20136.","journal-title":"New Microbes New Infect"},{"key":"609_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.eimc.2019.12.014","volume":"39","author":"M\u00c1 Asencio-Egea","year":"2021","unstructured":"Asencio-Egea M\u00c1, Gait\u00e1n-Pitera J, Huertas-Vaquero M, Carranza-Gonz\u00e1lez R, Rom\u00e1n-Ortiz C, Lara-Fuella N. Diseminaci\u00f3n interhospitalaria de Klebsiella pneumoniae ST512 productora de KPC-3. detecci\u00f3n por MALDI-TOF. Enferm Infecc Microbiol Clin. 2021;39:83\u20136.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"609_CR39","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.2147\/IDR.S226416","volume":"12","author":"D Di Tella","year":"2019","unstructured":"Di Tella D, Tamburro M, Guerrizio G, Fanelli I, Sammarco ML, Ripabelli G. Molecular epidemiological insights into colistin-resistant and carbapenemases-producing clinical Klebsiella pneumoniae isolates. Infect Drug Resist. 2019;12:3783\u201395.","journal-title":"Infect Drug Resist"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00609-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-023-00609-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00609-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T12:03:43Z","timestamp":1690977823000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-023-00609-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["609"],"URL":"https:\/\/doi.org\/10.1186\/s12941-023-00609-8","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,2]]},"assertion":[{"value":"31 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Helsinki Declaration and approved by the \u201cComite de Etica del Hospital Clinica Kennedy\u201d [HCK-CEISH-19-0016]. Informed consent was waived by the Ethical Committee, to collect the strains from biological samples and anonymized clinical information. No data could be gathered from the subjects from whom the strains were isolated. We gained approval from each institution's clinical records committee. There was no risk to the subjects, and the study was found to be of high public health benefit.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}